Skip to main content

New Center for Tumor-Multiplying Diseases at Stanford Hospital

By March 16, 2012December 18th, 2023Awareness, NF2-SWN, Science & Research

On March 15, 2012, Stanford Hospital announced the launch of a new program, led by Dr. Steven Chang, to treat rare tumor-multiplying diseases.


Stanford’s program includes a team of 12 specialists in several fields: neurosurgery, epilepsy, neuro-ophthalmology, neuro-oncology, neuro-otology, neuro-interventional radiology, urology, and general surgery.


“The goal,” Chang said, “is to give cutting-edge care for conditions like Knodel’s, neurofibromatosis 2 (NF2) and others including another form of neurofibromatosis, schwannomatosis tuberous sclerosis, von Hippel-Lindau disease, Sturge Weber syndrome and hemorrhagic telangiectasia.”


Please click here to read more